Limitations, agreements, and source contact

High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma · Source last updated 2020-05-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

ynieto@mdanderson.org

organization

UT MD Anderson Cancer Center

phone

713-792-2466

title

Dr. Nieto, Yago, M.D./Stem Cell Transplantation

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice